Home / NYT / Breakthrough Drug for Covid-19 May Be Risky for Mild Cases

Breakthrough Drug for Covid-19 May Be Risky for Mild Cases



By BY RONI CARYN RABIN from NYT Health


your-feed-science, Coronavirus (2019-nCoV), Dexamethasone (Drug), Clinical Trials, Immune System, Drugs (Pharmaceuticals), Steroids
Breakthrough Drug for Covid-19 May Be Risky for Mild Cases Breakthrough Drug for Covid-19 May Be Risky for Mild Cases Reviewed by Moltivie on June 25, 2020 Rating: 5

No comments:

Subscribe to: Post Comments ( Atom )
Powered by Blogger.